Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

The potential of adjuvant mRNA–lipoplex neoantigen vaccines to induce durable ... vaccines prime long-lived CD8+ T cells in pancreatic cancer, Nature (2025). DOI: 10.1038/s41586-024-08508-4 ...

Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...

I just wanted to extend that time." The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and attack the tumor. During surgery ...